JP2023535366A5 - - Google Patents
Info
- Publication number
- JP2023535366A5 JP2023535366A5 JP2023503124A JP2023503124A JP2023535366A5 JP 2023535366 A5 JP2023535366 A5 JP 2023535366A5 JP 2023503124 A JP2023503124 A JP 2023503124A JP 2023503124 A JP2023503124 A JP 2023503124A JP 2023535366 A5 JP2023535366 A5 JP 2023535366A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063052502P | 2020-07-16 | 2020-07-16 | |
| US63/052,502 | 2020-07-16 | ||
| PCT/US2021/041737 WO2022015922A1 (en) | 2020-07-16 | 2021-07-15 | Hla class ii-restricted drb t cell receptors against ras with g12v mutation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023535366A JP2023535366A (ja) | 2023-08-17 |
| JP2023535366A5 true JP2023535366A5 (https=) | 2024-07-18 |
| JPWO2022015922A5 JPWO2022015922A5 (https=) | 2024-07-18 |
Family
ID=77265247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023503124A Pending JP2023535366A (ja) | 2020-07-16 | 2021-07-15 | Ｇ１２ｖ変異を有するｒａｓに対するｈｌａクラスｉｉ拘束性ｄｒｂ ｔ細胞受容体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230257440A1 (https=) |
| EP (1) | EP4182029B1 (https=) |
| JP (1) | JP2023535366A (https=) |
| KR (1) | KR20230046294A (https=) |
| CN (1) | CN116348484A (https=) |
| AU (1) | AU2021309958A1 (https=) |
| CA (1) | CA3185483A1 (https=) |
| ES (1) | ES3063075T3 (https=) |
| WO (1) | WO2022015922A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022227029A1 (en) | 2021-02-26 | 2023-08-31 | New York University | Compositions and methods comprising antibodies that bind to covalent peptide conjugates |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003265948B8 (en) | 2002-09-06 | 2009-09-03 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy |
| US8383099B2 (en) | 2009-08-28 | 2013-02-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Adoptive cell therapy with young T cells |
| ES2635335T3 (es) * | 2010-09-20 | 2017-10-03 | Biontech Cell & Gene Therapies Gmbh | Receptores de células T específicos de antígeno y epítopos de células T |
| WO2012129201A1 (en) | 2011-03-22 | 2012-09-27 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of growing tumor infiltrating lymphocytes in gas-permeable containers |
| MX384919B (es) * | 2014-11-26 | 2025-03-14 | Us Health | Receptores de células t de kras anti-mutado. |
| JP7185524B2 (ja) * | 2015-09-15 | 2022-12-07 | アメリカ合衆国 | Ｈｌａ－ｃｗ８拘束性の変異ｋｒａｓを認識するｔ細胞受容体 |
| EP3684799A1 (en) * | 2017-09-20 | 2020-07-29 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Hla class ii restricted t cell receptors against mutated ras |
| EP3720478A1 (en) * | 2017-12-04 | 2020-10-14 | The United States of America, as represented by the Secretary, Department of Health and Human Services | Hla class i-restricted t cell receptors against mutated ras |
| EP3749349A4 (en) * | 2018-02-10 | 2021-11-24 | Berkeley Lights, Inc. | MUTANT IDH1 SPECIFIC T CELL RECEPTOR |
-
2021
- 2021-07-15 CN CN202180050745.7A patent/CN116348484A/zh active Pending
- 2021-07-15 WO PCT/US2021/041737 patent/WO2022015922A1/en not_active Ceased
- 2021-07-15 ES ES21752355T patent/ES3063075T3/es active Active
- 2021-07-15 KR KR1020237005176A patent/KR20230046294A/ko active Pending
- 2021-07-15 EP EP21752355.4A patent/EP4182029B1/en active Active
- 2021-07-15 AU AU2021309958A patent/AU2021309958A1/en active Pending
- 2021-07-15 JP JP2023503124A patent/JP2023535366A/ja active Pending
- 2021-07-15 US US18/015,781 patent/US20230257440A1/en active Pending
- 2021-07-15 CA CA3185483A patent/CA3185483A1/en active Pending